HomeTopics › Intermittent Fasting

Intermittent Fasting

GMJ News knowledge hub · last reviewed August 2026 · Georgian Medical Journal

SummaryStatisticsGlossaryGMJ newsFAQDocumentsOrganizationsResearch

Intermittent fasting — whether time-restricted eating within a daily window, alternate-day fasting, or the 5:2 pattern — is genuinely effective for weight loss, and the reason is considerably less exotic than the discourse surrounding it: restricting when people eat reduces how much they eat, and randomised trials comparing fasting protocols with continuous calorie restriction matched for total energy consistently find equivalent outcomes rather than any metabolic advantage (WHO). This is a useful finding rather than a dismissive one, because adherence is the binding constraint in all weight management and a simpler rule that some people can follow indefinitely may outperform a calorie target they abandon. The claims that do not survive scrutiny are the mechanistic ones: autophagy has never been measured in fasting humans in a way that supports the timelines circulated online, the metabolic switching narrative outruns the human data, and the TREAT trial found that 16:8 eating without calorie counting produced minimal weight loss with a concerning signal for lean mass — while fasting is genuinely unsuitable for people with type 1 diabetes, on sulfonylureas or insulin, in pregnancy, or with any history of an eating disorder.

Key messages

SETTLED: effective for weight loss, and not superior to equivalent calorie restriction
Randomised trials and their meta-analyses consistently find that intermittent fasting protocols produce weight loss comparable to continuous energy restriction when total energy intake is matched. There is no demonstrated metabolic advantage. This is not a dismissal: it establishes that fasting works through the mechanism it appears to work through — eating less — and that the choice between approaches should be made on adherence rather than on physiology.
THE REAL ARGUMENT FOR IT: adherence, not metabolism
Adherence is the binding constraint in every weight management intervention, and a simple structural rule that requires no counting, weighing or tracking suits some people far better than a daily calorie target. For those individuals, a strategy they sustain for years outperforms a superior strategy they abandon in six weeks. This is a legitimate and evidence-consistent reason to recommend it, and it is a considerably stronger argument than the mechanistic claims usually offered.
UNSUPPORTED: the autophagy claims circulating online
Autophagy is a genuine and important cellular process, and fasting induces it in animal models. The claims that specific benefits begin at 16, 18 or 24 hours of fasting in humans have no direct human measurement behind them: autophagy has not been quantified in fasting humans in a way that would support any such timeline, the process is tissue-specific and continuous rather than switched on at a threshold, and the extrapolation from rodent studies ignores that a mouse fasting 16 hours has depleted a far greater proportion of its metabolic reserve than a human doing the same.
THE TREAT TRIAL: time-restricted eating without calorie awareness performs poorly
The TREAT randomised trial assigned participants to 16:8 time-restricted eating or three structured meals per day without calorie prescription, and found minimal difference in weight loss — with a signal that a substantial proportion of the weight lost in the time-restricted group was lean mass. Subsequent trials have not consistently replicated the lean mass finding, but the central lesson holds: time-restricted eating produces results when it reduces energy intake, and simply narrowing the window without attention to what is eaten within it frequently does not.
CONTRAINDICATIONS THAT ARE ROUTINELY IGNORED
Intermittent fasting is unsafe or inappropriate for several groups and this is rarely stated alongside the promotion. Type 1 diabetes and anyone using insulin or sulfonylureas face hypoglycaemia risk requiring medication adjustment and supervision. Pregnancy and breastfeeding. Any current or past eating disorder, where structured restriction and permitted-window thinking can reactivate pathology. Children and adolescents. Frailty and sarcopenia in older adults, where protein distribution across the day matters for muscle protein synthesis. Advanced kidney or liver disease. Several medications require food.
GENUINELY OPEN: circadian timing and early versus late eating windows
The most scientifically interesting remaining question concerns not fasting duration but timing. Human insulin sensitivity, thermogenesis and glucose tolerance follow a circadian rhythm, being higher in the morning, and small controlled trials of early time-restricted eating — with the window ending in the afternoon or early evening — have shown improvements in insulin sensitivity, blood pressure and oxidative stress that were partly independent of weight loss. The findings are consistent but the trials are small and short, and late eating windows, which most people actually adopt, have not shown the same effects.

Key statistics

Equivalent
weight loss to continuous calorie restriction when total energy is matched in RCTs
JAMA IM/Cochrane
No human data
supporting the specific autophagy timelines circulated online
Autophagy/Cell Metab
TREAT trial
16:8 without calorie attention produced minimal weight loss, with a lean mass signal
JAMA IM 2020
Adherence
the only evidence-consistent reason to prefer fasting over other approaches
Obesity Reviews
Early window
early time-restricted eating shows weight-independent metabolic effects in small trials
Cell Metab
Contraindicated
in T1DM, insulin or sulfonylurea use, pregnancy, eating disorder history, and childhood
ADA/BDA

Intermittent fasting — where the disagreement actually lies

Source: Bars show strength of supporting evidence. Fasting works; the contested part is why, and whether it works better than alternatives.

Glossary of key terms

Fasting protocols
Definitions
Time-restricted eating confines all intake to a daily window, commonly 8 hours (16:8), sometimes 10 or 6 hours, with the window position varying — early TRE ends in the afternoon or early evening, late TRE extends into the night. Alternate-day fasting alternates unrestricted days with fasting or very-low-energy days, typically around 500 kcal. The 5:2 pattern applies two non-consecutive very-low-energy days per week. Periodic prolonged fasting extends beyond 24 hours and requires medical supervision beyond short durations. These are pharmacologically and behaviourally different interventions and evidence for one does not transfer to another, which is a frequent source of confusion when trial results are generalised across the whole category.
Autophagy — what is actually known
Cell biology
Autophagy is the regulated catabolic process by which cells degrade and recycle damaged organelles and misfolded proteins via lysosomes, and it is fundamental to cellular homeostasis, with dysregulation implicated in neurodegeneration, cancer and ageing. It is nutrient-sensitive, inhibited by mTOR signalling and stimulated by AMPK activation, so energy deprivation upregulates it. What is not established is the human dose-response: autophagic flux cannot be measured non-invasively, human data derive largely from muscle or leucocyte biopsies with indirect markers such as LC3-II conversion, findings are inconsistent, and the process is continuous and tissue-specific rather than initiated at a threshold hour. The confident timelines circulating in popular content are extrapolations from rodent work presented as human physiology.
Metabolic switching and ketone bodies
Physiology
The proposal that intermittent fasting confers benefit through repeated transition from glucose to fatty acid and ketone metabolism, with ketone bodies acting as signalling molecules affecting gene expression, inflammation and neuronal function. The mechanistic biology is real: beta-hydroxybutyrate inhibits histone deacetylases and the NLRP3 inflammasome in experimental systems. The gap is between mechanism and outcome — demonstrating that a pathway is activated does not demonstrate clinical benefit, and the trials matching energy intake find no advantage. This is a recurring pattern in nutrition: an elegant mechanism generates confident recommendations before outcome data exist, and the mechanism frequently survives while the recommendation does not.
Muscle mass, protein distribution and older adults
Geriatrics/Nutrition
Muscle protein synthesis responds to protein intake in a threshold and saturable manner, with roughly 25-40g of high-quality protein per meal required to maximally stimulate synthesis in older adults, who exhibit anabolic resistance. Compressing intake into a narrow window makes it harder to distribute protein across multiple stimulatory doses and easier to fall below total protein requirements. In a population already at risk of sarcopenia, frailty and falls, this is a genuine concern that receives little attention in fasting promotion. Resistance exercise and adequate protein intake are the interventions with the strongest evidence for preserving function in older adults, and any dietary pattern that compromises either warrants caution.
Fasting and eating disorders
Psychiatry
Structured fasting protocols share features with restrictive eating pathology — rule-governed eating windows, permitted and forbidden times, compensatory logic and moral framing of adherence — and can precipitate or perpetuate disordered eating in susceptible individuals. Binge eating in the permitted window following prolonged restriction is a recognised and mechanistically predictable pattern. Any current or historical eating disorder is a contraindication, and clinicians should ask directly rather than wait for disclosure, since patients frequently present fasting as a health behaviour. The risk is amplified in adolescents and in the online environments where fasting content circulates alongside body composition and physique material.
Ramadan fasting as a natural experiment
Global health
Ramadan involves daily fasting from dawn to sunset for a lunar month by well over a billion people, providing a large-scale observational context. Studies generally find modest weight loss during the month with substantial regain afterwards, transient changes in lipids and blood pressure, and dehydration risk that varies greatly with latitude and season. Clinically important considerations include hypoglycaemia in people with diabetes taking insulin or sulfonylureas, requiring pre-Ramadan medication review and risk stratification as set out in IDF-DAR guidance; medication timing for chronic conditions; and increased risk in pregnancy and in chronic kidney disease. Religious exemptions exist for illness, and clinicians should be able to discuss this without either dismissing the practice or ignoring the risks.

Latest GMJ coverage

Intermittent Fasting Rewires Brain and Gut Microbiome, New Study Reveals
08/06/2026
The Master Clock: How Your Brain’s Circadian Rhythm Controls Sleep, Hunger, and Mood
06/08/2026

Frequently asked questions 12 Q&A — structured for Google featured snippets and AI discovery

Knowledge hub: guidelines, conventions and reports

Organizations working in migration and health

Related health topics

ObesityKetogenic dietDiabetes and fasting safetyRestrictive eating riskNutritionSarcopenia and protein distribution

About this hub. Produced by the GMJ News Editorial Team as a public-good service. Every statistic is linked to its primary source. Documents are preserved in the GMJ Repository with full attribution. Georgian Medical Journal · Contact the editorial team
GMJ BriefsView all →